Qingdao Baheal Medical Inc.
SHZ: 301015.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Gang Fu
- Employees
- 3,064
- Headquarters
- Qingdao, China
- IPO year
- 2021
- Market cap
- CN¥13.0B
- Website
- https://www.bahealpharma.com
Loading 301015…
Loading profile data…Frequently asked questions about 301015
What does Qingdao Baheal Medical Inc. (301015.SZ) do?
Qingdao Baheal Medical INC. engages in research and development, production, and sale of pharmaceutical products. The company offers vitamin D calcium chewable tablets. The company was founded in 2005 and is based in Qingdao, China.
Where does 301015.SZ trade?
Qingdao Baheal Medical Inc. (301015.SZ) trades on the Shenzhen Stock Exchange.
What sector is 301015.SZ in?
Qingdao Baheal Medical Inc. (301015.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Qingdao Baheal Medical Inc.?
Gang Fu is the chief executive officer of Qingdao Baheal Medical Inc. (301015.SZ).
Where is Qingdao Baheal Medical Inc. headquartered?
Qingdao Baheal Medical Inc. is headquartered in China.
Does 301015.SZ pay a dividend?
Yes — Qingdao Baheal Medical Inc. (301015.SZ) paid a trailing twelve-month dividend of CNY 0.76 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 301015.SZ go public?
Qingdao Baheal Medical Inc. (301015.SZ) completed its initial public offering in 2021.